Fannie Mae, Freddie Mac shares tumble after conservatorship comments
On Friday, BMO Capital Markets adjusted its outlook on Infosys (NSE:INFY) Technologies (NYSE:INFY), with analyst Keith Bachman reducing the price target on the company’s shares to $18 from the previous $25. Despite the price target adjustment, the firm maintained a Market Perform rating on the stock. The current stock price of $16.14 represents a significant 27.6% decline over the past six months, though InvestingPro analysis suggests the stock is currently undervalued, with analyst targets ranging from $17 to $25.60.
Bachman’s revision follows Infosys’ fiscal year 2026 guidance, which indicated a year-over-year constant currency (CC) growth of 0-3%. This forecast was perceived as falling short of market expectations, particularly given the company’s recent revenue growth of 3.02% and strong financial health score. The guidance, which includes projections for the upcoming financial year, also considers the potential impact of economic conditions, ranging from a possible weakening to a slight improvement. InvestingPro subscribers can access 13 additional key insights about Infosys’s financial health and growth prospects through the comprehensive Pro Research Report.
The updated guidance from Infosys takes into account one quarter of revenue from In-Tech M&A but does not include the effects of two additional deals announced on the same day. Management has expressed that these deals, if closed in the first quarter as anticipated, could contribute an additional 40-50 basis points to the annual growth rate.
Furthermore, Infosys projected that third-party revenues in fiscal year 2026 would be lower than those in the previous year. However, the company’s management assured that existing deals are ramping up according to plan. The revised guidance and commentary from management provide a detailed picture of Infosys’ expectations and strategy for the upcoming financial period.
In other recent news, Infosys Ltd. has reported several significant developments that investors should note. The company has projected a year-over-year constant currency revenue growth of 0-3% for fiscal year 2026, excluding acquisitions, which has not met market expectations. This cautious guidance has led to multiple analysts adjusting their price targets for Infosys. Bernstein SocGen reduced its target to INR1,680 while maintaining an Outperform rating, noting the challenging demand environment. UBS also lowered its target to INR1,850 but kept a Buy rating, highlighting potential support from smaller deals and carryover revenue. Jefferies cut its target to INR1,835, citing growth concerns but still recommended a Buy, pointing out the attractive risk-reward balance. Stifel has adjusted its target to $18, maintaining a Hold rating, as they anticipate modest revenue growth in the latter half of fiscal year 2026. Despite these revised targets, analysts like Jefferies remain optimistic about Infosys due to its improved free cash flow conversion and higher payouts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.